Magellan

Magellan is a private Australian company with expertise in research, development and manufacturing of stem cells for the treatment of osteoarthritis. We lead the way globally in scientific, clinical and commercial expertise for stem cell supply and development, for both autologous treatments which use the patient’s own cells, and allogeneic treatments which use selected donor cells. We have over ten years of stem cell commercial manufacturing expertise and have cultured more than 300 billion stem cells during this time.